Completed NA INTERVENTIONAL 3-arm
NCT01735825
Treatment of Coronary In-Stent Restenosis (TIS)
Prospective Randomised Study Comparing Efficacy of Treatment Coronary In-stent Restenosis Using Drug Eluting Paclitaxel-coated Balloon and Drug Eluting Stent With Everolimus.
Sponsor: University Hospital Ostrava
Conditions
Restenosis
Interventions
drug eluting stent with everolimus paclitaxel-coated balloon catheter with Iopromide coating seal-wing paclitaxel-eluting balloon catheter
Updated 1 time since 2024 Last updated: Dec 6, 2022 Started: Jan 31, 2012 Primary completion: Jul 31, 2015 Completion: Jun 30, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A NA clinical study on Restenosis, this trial is completed. The trial is conducted by University Hospital Ostrava and has accumulated 1 data snapshot since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
1 version recorded Completed — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- University Hospital Ostrava
Data source: University Hospital Ostrava
For direct contact, visit the study record on ClinicalTrials.gov .